 |
 |
| Launched a year ago, the "Freedom" smart watch from Masimo features the company's ground breaking optical pulse oximetry technology. The firm's "W1" device is the first FDA-cleared watch to provide continuous real-time oxygen saturation and pulse rate for over-the-counter use - something that Masimo CEO Joe Kiani describes as "22nd Century healthcare". Image: Masimo/Business Wire. |
| © 2024 SPIE Europe |
|
